Psyence Biomedical Ltd. (PBM)
4.20
-0.13
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
4.20
0.00 (0.00%)
After-Hours: 20:00
Psyence Biomedical Total Assets (Quarterly) : 12.81M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 12.81M |
| September 30, 2024 | 2.254M |
| December 31, 2023 | |
| September 30, 2023 | 12.68M |
| June 30, 2023 | 16.73M |
| March 31, 2023 | 16.40M |
| December 31, 2022 | 258.93M |
| Date | Value |
|---|---|
| September 30, 2022 | 256.48M |
| June 30, 2022 | 255.87M |
| March 31, 2022 | 255.98M |
| December 31, 2021 | 256.22M |
| September 30, 2021 | 0.218M |
| June 30, 2021 | 0.1843M |
| March 31, 2021 | 0.0964M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 1.296B |
| Aurinia Pharmaceuticals, Inc. | 792.26M |
| enGene Therapeutics, Inc. | 307.52M |
| Medicus Pharma Ltd. | 19.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.9431M |
| Shareholders Equity (Quarterly) | 11.87M |